NO975692L - Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi - Google Patents

Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi

Info

Publication number
NO975692L
NO975692L NO975692A NO975692A NO975692L NO 975692 L NO975692 L NO 975692L NO 975692 A NO975692 A NO 975692A NO 975692 A NO975692 A NO 975692A NO 975692 L NO975692 L NO 975692L
Authority
NO
Norway
Prior art keywords
bone loss
biphosphonates
connection
immunosuppressive therapy
prevent bone
Prior art date
Application number
NO975692A
Other languages
English (en)
Other versions
NO975692D0 (no
Inventor
Anastasia G Daifotis
Ashley J Yates
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO975692D0 publication Critical patent/NO975692D0/no
Publication of NO975692L publication Critical patent/NO975692L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bisfosfonat, spesielt alendronat, kan forhindre eller avstedkomme behandling av tap av benmasse forbundet med immun- suppressiv terapi, enten den immunsup- ; pressive terapi er forbundet med en organtransplantasjon eller ikke.
NO975692A 1995-06-06 1997-12-05 Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi NO975692L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/471,466 US5616571A (en) 1995-06-06 1995-06-06 Bisphosphonates prevent bone loss associated with immunosuppressive therapy
PCT/US1996/008398 WO1996039151A1 (en) 1995-06-06 1996-06-03 Bisphosphonates prevent bone loss associated with immunosuppressive therapy

Publications (2)

Publication Number Publication Date
NO975692D0 NO975692D0 (no) 1997-12-05
NO975692L true NO975692L (no) 1997-12-05

Family

ID=23871741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975692A NO975692L (no) 1995-06-06 1997-12-05 Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi

Country Status (14)

Country Link
US (1) US5616571A (no)
EP (1) EP0831844A4 (no)
JP (1) JPH11507044A (no)
KR (1) KR19990022380A (no)
CA (1) CA2223400A1 (no)
CZ (1) CZ288906B6 (no)
EA (1) EA000964B1 (no)
HU (1) HUP9900886A3 (no)
IL (1) IL122149A (no)
NO (1) NO975692L (no)
NZ (1) NZ310000A (no)
PL (1) PL323797A1 (no)
SK (1) SK163797A3 (no)
WO (1) WO1996039151A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661080B2 (en) * 1991-11-22 1995-07-13 Warner Chilcott Company, Llc Risedronate delayed-release compositions
KR19980702210A (ko) * 1995-02-17 1998-07-15 폴락 돈나 엘 비척추골 골절의 위험률을 감소시키는 방법
CZ116999A3 (cs) * 1996-10-04 1999-09-15 Merck And Co., Inc. Vodný tekutý farmaceutický prostředek
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
AU741818C (en) * 1997-07-22 2003-01-09 Merck Sharp & Dohme Corp. Method for inhibiting bone resorption
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
AU6427599A (en) * 1998-10-15 2000-05-01 Merck & Co., Inc. Methods for stimulating bone formation
US6414006B1 (en) 1998-10-15 2002-07-02 Merck Frosst Canada & Co. Methods for inhibiting bone resorption
US6331533B1 (en) 1998-11-16 2001-12-18 Merck & Co., Inc. Method for inhibiting dental resorptive lesions
CZ20013912A3 (cs) 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
AU2001243385B2 (en) * 2000-03-02 2006-11-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Combination chemotherapy
NZ527157A (en) * 2001-03-01 2005-04-29 Emisphere Tech Inc Compositions for delivering bisphosphonates
AU2003226148A1 (en) * 2002-04-05 2003-10-27 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
US20040097468A1 (en) * 2002-11-20 2004-05-20 Wimalawansa Sunil J. Method of treating osteoporosis and other bone disorders with upfront loading of bisphosphonates, and kits for such treatment
US20050181043A1 (en) * 2004-02-12 2005-08-18 Indranil Nandi Alendronate salt tablet compositions
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability
EP1865928A1 (en) * 2005-03-17 2007-12-19 Elan Pharma International Limited Nanoparticulate biphosphonate compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530603D0 (en) * 1985-12-12 1986-01-22 Leo Pharm Prod Ltd Chemical compounds
CZ282889B6 (cs) * 1991-12-17 1997-11-12 Procter And Gamble Pharmaceuticals, Inc. Použití difosfonátů a parathormonu pro výrobu léčiva, které se používá pro léčení osteoporosy
HUT70210A (en) * 1992-06-30 1995-09-28 Procter & Gamble Pharma Use of phosphonates for the treatment of osteoporosis
US5578593A (en) * 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
CA2151240A1 (en) * 1992-12-23 1994-07-07 Donna T. Whiteford Biophosphonate/estrogen therapy for treating and preventing bone loss
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
TW398975B (en) * 1994-07-22 2000-07-21 Lilly Co Eli Pharmaceutical composition for inhibiting bone loss
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
CN1157566A (zh) * 1994-09-09 1997-08-20 普罗克特和甘保尔公司 用于骨质疏松症的膦酸盐类和甲状旁腺激素

Also Published As

Publication number Publication date
AU6030996A (en) 1996-12-24
NZ310000A (en) 2000-07-28
EA000964B1 (ru) 2000-08-28
WO1996039151A1 (en) 1996-12-12
HUP9900886A3 (en) 2002-04-29
IL122149A (en) 2001-03-19
JPH11507044A (ja) 1999-06-22
KR19990022380A (ko) 1999-03-25
NO975692D0 (no) 1997-12-05
AU696097B2 (en) 1998-09-03
US5616571A (en) 1997-04-01
IL122149A0 (en) 1998-04-05
PL323797A1 (en) 1998-04-27
EA199800011A1 (ru) 1998-06-25
CA2223400A1 (en) 1996-12-12
CZ389897A3 (cs) 1998-07-15
CZ288906B6 (cs) 2001-09-12
SK163797A3 (en) 1998-07-08
EP0831844A4 (en) 1998-12-30
HUP9900886A2 (hu) 2001-04-28
EP0831844A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
CA2214122A1 (en) Composite membrane
WO1998032412A3 (en) Bistable spring construction for a stent and other medical apparatus
ES2101499T3 (es) Fibras.
DK0650374T3 (da) Anvendelse af et porøst materiale på basis af calciumcarbonat som bærer for en vækstfaktor ved fremstillingen af et bioreso
ATE397005T1 (de) Sialyl-lewisa und sialyl-lewisx epitope analoge
AU2243092A (en) Extended-release form of diltiazem
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
BG102998A (en) Spiro-piperidine derivatives and their application as therapeutical forms
WO1993020757A3 (en) Vascular implant system
CA2257976A1 (en) Compositions and methods for coating medical devices
CA2264013A1 (fr) Compositions stables a base de polyorganosiloxanes a groupements fonctionnels reticulables et leur utilisation pour la realisation de revetements anti-adherents
EA199800011A1 (ru) Способ лечения или предупреждения остеопороза
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
CA2218289A1 (en) Cd45rb binding compounds for the prevention of transplant rejection
NO964539L (no) Kollagen-preparat for kontrollert avgivelse av virkestoffer
EP1356818A3 (de) Medikament, insbesondere zur Modulation der Immunantwort bei der Bekämpfung von Viren, Tumoren, Bakterien und Parasiten
AU1724501A (en) Bioabsorbable, osteopromoting fixation plate
EP0771551A3 (en) Prosthetic bearing element and implant incorporating such an element
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
AU3170500A (en) Method for preparing an antimicrobial composition
TW330244B (en) The optical system with variable magnified rate
AU6505898A (en) Sperm extender comprising native phosphocaseinate or beta-lactoglobulin, method for preparing same and uses
GB2304070B (en) Implant having integrally-textured, hemocompatible, blood-contacting surfaces and method for producing the same
DE69906801D1 (de) Beschichtungszusammensetzung
MX9709906A (es) Uso de bisfosfonatos para preparar composiciones para prevenir perdida de hueso asociada con terapia inmunosupresora.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application